Solid Biosciences (SLDB) Operating Income Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.47% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -12.10% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.35% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 55.96% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -21.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.40% |
| Dec 31, 2025 | -12.64% |
| Sep 30, 2025 | -31.50% |
| Jun 30, 2025 | -17.99% |
| Mar 31, 2025 | -16.44% |
| Dec 31, 2024 | -28.85% |
| Sep 30, 2024 | -24.96% |
| Jun 30, 2024 | -14.14% |
| Mar 31, 2024 | -16.74% |
| Dec 31, 2023 | -1.41% |
| Sep 30, 2023 | -2.88% |
| Jun 30, 2023 | -12.26% |
| Mar 31, 2023 | -6.04% |
| Dec 31, 2022 | -2.25% |
| Sep 30, 2022 | 10.74% |
| Jun 30, 2022 | 2.00% |
| Mar 31, 2022 | 5.75% |
| Dec 31, 2021 | 5.90% |
| Sep 30, 2021 | 1.99% |
| Jun 30, 2021 | -0.92% |
| Mar 31, 2021 | -1.87% |
| Dec 31, 2020 | -12.08% |
| Sep 30, 2020 | -15.72% |
| Jun 30, 2020 | -16.87% |
| Mar 31, 2020 | -23.92% |